top of page

Search Results

Results found for "Frizzled GPCR"

  • How System-Level GPCR Thinking Prevents Discovery Failures

    Upcoming events:  Adhesion GPCR Workshop; GRC—Transporters, Ion Channels & GPCRs; MPGPCR Joint Satellite GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. GPCR Premium Membership Gives You an Edge Premium gives GPCR scientists and biotech teams a single, trusted GPCR and the offered resources in my work sphere." GPCR research and education across the global community.

  • How a Failed Experiment Created a Powerful GPCR Imaging Tool

    Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. The Moment a Failed Tool Became a GPCR Imaging Breakthrough What the compound did reliably do was label This solved a long-standing problem in GPCR biology: You can't understand signaling if you can’t see  The Larger Lesson for Scientists and Innovators This story isn’t just about a GPCR imaging tool.

  • From Farm Fields to GPCR Discovery, GLP-1 and GIP

    Following the Data Into GPCR, Metabolic Disease and GLP-1 After his PhD, Hodson entered neuroendocrinology GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR Emerging direction: Multi-target GPCR + myostatin-pathway combinations. Can GPCRs act as “delivery ZIP codes” for targeted therapies?

  • How Schild Analysis Protects Your Conclusions in GPCR Research

    Listen to the episode ➤ Quick Links Assess GPCR Biased Signaling of Agonist How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling GPCR Premium Membership Gives You an Edge Premium delivers a clear, noise-free stream of GPCR intelligence GPCR innovation is accelerating. GPCR Team

  • Ben Clements on Rescuing Opioids with GPCR Modulators

    His work highlights how foundational GPCR science can drive therapeutic innovation. The GPCR Angle Ben sees GPCRs as untapped goldmines for drug discovery. Ready to dive deeper into GPCR drug discovery? Want to push the boundaries of GPCR drug discovery? Start learning with our GPCR University today. _______________ Keyword Cloud: GPCR research community , GPCR drug discovery, mu-opioid receptor, positive allosteric modulators, GPCR training program, GPCR

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    GPCR. Dear Dr. GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR resources, connect new scientists, and earn rewards  for helping expand access to GPCR knowledge GPCR About Dr. GPCR Dr.

  • Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox

    For decades, GPCRs have been the cornerstone of pharmacology. GPCR Modeling in Context: Then and Now When Carlsson entered the GPCR field in the early 2000s, structural Why Predictive GPCR Modeling Matters Now The convergence of machine learning, improved GPCR structures Want to go deeper into GPCR modeling? Dr. GPCR Podcast Push the boundaries of what's possible 👉 Join the Dr.

  • Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024

    Get your space suits on, GPCR cadets! up with a series of cosmic GPCR events for the year ahead. Discounted GPCR courses - because who doesn't love a good deal?  From 2025, only Premium Members will have access to Classified GPCR News. Classified GPCR News  Let’s dive into the   Classified GPCR News from October 28th to November 3rd, 2024

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid If you’re building tools or careers in GPCR science, this is your playbook. It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    Before your GPCR ligand ever meets its receptor, it meets the enzymes that determine whether it survives Discovery Program So what does that mean for discovery scientists designing the next generation of GPCR Even the most elegant GPCR ligand can fail if it never reaches its receptor. GPCR members save 50%+  with your Weekly News code. 👉 Join Terry’s Corner & Secure Your Spot for the Kenakin with your own enzyme or GPCR interaction puzzles.

  • Why Kinetics Matter More Than Kd in GPCR Drug Discovery

    Welcome GPCR Fans,   Every discovery-phase decision you make shapes your entire pipeline trajectory—and Upcoming events:  5th MMCS New Trends in Drug Discovery; GPCR-UK Network Meeting; neuroGPCR Symposium Must-read publications:  GPCRchimeraDB: Database of engineered GPCR designs. GPCR University Course Attendee Dr. The pace of GPCR innovation is accelerating.

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    GPCR , the global nonprofit platform dedicated to advancing GPCR science through education, community GPCR Ecosystem. GPCR Podcast To mark the spotlight, Dr. GPCR  invited Dr. Eric Trinquet  to the Dr. GPCR. GPCR Dr.

  • First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity

    2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology as new videos are released: ▶️ https://www.youtube.com/@TerryPharmacologyCorner New White Paper on GPCR School of Medicine, has authored a new white paper in collaboration with Eurofins DiscoverX: Assess GPCR ) Systematic comparison of biased agonists using modern functional assays For scientists working in GPCR Forty years of pharmacological expertise — organized into a year-round framework for serious GPCR scientists

  • Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?

    In the high-stakes world of GPCR drug discovery , breakthrough science isn't enough. GPCR, we recognized this core problem. This is the essence of de-risking GPCR programs through operational excellence. the entire GPCR program as a single, interconnected entity. The GPCR Precision Blueprint is more than a concept.

  • Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026

    Must-read publications:  GPCRs in neurological disorders; OSTα-OSTβ structure; GPCR–G protein–β-arrestin GPCR Podcast—GPCR Assay Strategy, Bias, and Translational Drug Discovery In this episode of the Dr. GPCR podcast , Dr. GPCR innovation is accelerating. GPCR Team

  • Ode to GPCRs

    The first Nobel prize that can be attributed to work related to GPCR-mediated signaling was the 1947 These odorant receptors (ORs) now account for about 60% of all identified human GPCRs. GPCR signaling, and location bias.[68–70] Further, our understanding of cross-talk between GPCR-mediated signaling pathways with other cellular signaling pathways, as well as non-signaling roles of GPCRs, Interaction of G-Protein βγ Complex with Chromatin Modulates GPCR- Dependent Gene Regulation.

  • Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game

    we explore how computational tools—especially AlphaFold —are helping crack the mystery of olfactory GPCRs The Problem: Hundreds of Receptors, Almost No Ligands Alessandro’s work focuses on olfactory GPCRs—nearly : Predicting the “Face” of a Receptor When Alessandro began his PhD, structural models of olfactory GPCRs —Alessandro Nicoli A New Era of GPCR Research AlphaFold didn’t just fill a gap—it shifted the focus of Start with our GPCR training program and get hands-on with virtual tools shaping the future of drug discovery

  • Why Intracellular Drugs May Hold the Key to GPCR Therapeutics

    of how residence time—not potency—predicts therapeutic coverage ✅ Insight into cryptic intracellular GPCR evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays   Why Intracellular GPCR Drugs Change the Game For decades, drug design has treated GPCRs as surface targets. GPCRs now have validated intracellular  allosteric sites. Subscribe to The Kenakin Brief today  ➤ #GPCRs #IntracellularDrugs #DiffusionBarriers #DrugResidenceTime

  • When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue

    A single successful GPCR imaging experiment can transform a project’s trajectory. Interdisciplinary design isn’t optional in GPCR imaging. It’s the catalyst. And the most striking validation came from in vivo GPCR imaging. Strong GPCR imaging tools come from strong interdisciplinary relationships.  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall  not because the target In accelerating GPCR drug discovery, the bottleneck isn’t target identification — it’s turning validated GPCR Kinetics: The Critical Data You Can’t Afford to Skip Equilibrium potency data only tells part of “GPCRs are nature’s prototype allosteric proteins. Everything they do is allosteric.” Kenakin with your own enzyme or GPCR interaction puzzles.

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    Enhance your GPCR research with deeper assay insights for more effective results. This Week’s GPCR Intelligence: If you want cleaner decisions, start with the system—then the ligand. Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates allosteric site on an orphan GPCR. 🔍 This Week in Dr. GPCR innovation is accelerating.

  • GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register

    GPCR is proud to partner with the 5th Annual GPCRs-Targeted Drug Discovery Summit.   Why the GPCR Drug Discovery Field Is Converging in Boston The GPCR field is in a genuinely exciting moment GPCR founder Dr. Yamina Berchiche will be there — if you're attending, reach out to connect. from biotech and pharma to advance GPCR programmes from discovery through translation — experts in GPCR ADCs, orally available cyclic peptides, and allosteric probes for Class B GPCRs.

  • How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights

    GPCR Premium: Sneak Peek Want the full classified brief? GPCR , our mission is simple but urgent: Accelerate GPCR biology and drug discovery by connecting scientists GPCR Podcast, the Revvity team built pHSense™ from the ground up by listening to what GPCR scientists GPCR innovation is accelerating. GPCR and the offered resources in my work sphere." — DrGPCR University Attendee GPCR innovation doesn

  • GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures

    Kenakin  highlighted a fundamental truth: GPCR systems do not offer stable, proportional input–output Teams equipped with deep GPCR pharmacology insights make different decisions. The sections below synthesize the key topics addressed during the AMA and highlight the GPCR pharmacology This is a core GPCR pharmacology insight:ligand → receptor → G protein is never the entire story. GPCR innovation is accelerating, and those who invest in deeper GPCR pharmacology insights today will

  • New Podcast, Sweet Structures & $2.2B GPCR Moves

    Hello Sweet GPCR Enthusiasts, This week at Dr. GPCR: a new podcast episode with Dr. GPCR Updates   New Podcast Episode  - When to Walk, When to Run with Dr. GPCR Store is live!   — A tale of detergent tails: GPCR activation beyond ligands .   GPCR Team

  • From DNA day to GPCR genomics

    What does DNA Day have to do with GPCRs? GPCR biology, the development of GPCR-targeted drugs, and the exploration of GPCRs as key regulators in the total count of GPCR genes in the human genome. The genetic variation in GPCRs is extensive; databases like GPCRdb provide a large database of genetic Structural bioinformatics analysis of variants on GPCR function.

  • Targeting Intracellular Allosteric Sites in GPCRs

    Exploring the intracellular allosteric site GPCRs represent one of the largest and most vital families For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in GPCR activity, enabling greater specificity and fewer side effects. allosteric site common in class A and class B GPCRs, particularly in chemokine receptors.

  • Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early

    As GPCR science and pharmacological innovation accelerate, timely guidance from foundational to advanced

  • GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions

    Welcome back GPCR fans, If your drug discovery strategy still relies on static GPCR models, you’re already Upcoming events:  GPCR-UK Network Meeting, neuroGPCR symposium, and Transatlantic ECI GPCR event—where GPCR Podcast Listener Why Dr. GPCR Premium 🔹 What’s included? The pace of GPCR innovation is accelerating.

  • Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery

    For drug hunters working at the GPCR interface, the difference between a successful lead and a dead-end For GPCR drug discovery, those hidden details can determine whether a compound advances or stalls. The Hidden Lever in GPCR Research In GPCR pharmacology, the conversation often centers on ligand properties—affinity In an era of accelerated GPCR-targeting innovation, these advantages define which programs advance and GPCR members save 50%+ with your Weekly News code) 👉   Explore Trailers & Join Today Why Terry’s Corner

bottom of page